HOME > OUR WORLD > BUSINESS > FORMULATIONS BUSINESS

Mexico

Mexico is the world’s 11th largest and LATAM’s 2nd largest pharmaceutical market sizing up to USD 14.5 billion. Grin, Lupin’s subsidiary in Mexico has over its five decades of existence emerged as a specialty pharmaceutical company developing and manufacturing branded ophthalmic products. The Company continues to outshine competition and the industry in the represented segments. Grin reported revenues of MXP 530 million in FY 2017 on the back of a healthy number of product approvals. Today, Grin holds the 4th position amongst the ophthalmic players in Mexico as it looks to build on its strength and gradually expand its therapeutic presence into other areas such as Respiratory, etc.

FORMULATIONS BUSINESS